PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Free Cash Flow (2021 - 2026)

PepGen (PEPG) posted Free Cash Flow of -$18.4 million for Q1 2026, down 16.3% sequentially from -$15.8 million in Q4 2025, and up 20.08% YoY from -$15.3 million in Q1 2025.

Analysis

PepGen (PEPG) Free Cash Flow (2021 - 2026) Analysis & Trends

PepGen has reported Free Cash Flow for 6 years, with the latest figure at -$18.4 million in Q1 2026.

  • Quarterly Free Cash Flow rose 20.08% year-over-year to -$18.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$77.3 million (up 7.28% YoY) and the FY2025 annual result came in at -$81.9 million, up 1.17% from the prior year.
  • Free Cash Flow fell to -$18.4 million in Q1 2026 per PEPG's latest filing, from -$15.8 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$13.2 million in Q2 2022 and troughed at -$24.2 million in Q3 2024.
  • A 5-year average of -$18.7 million and a median of -$18.5 million in 2023 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2022 and 2023: Free Cash Flow plunged 342.93% in 2022, then increased 20.97% in 2023.
  • Over 5 years, Free Cash Flow stood at -$14.5 million in 2022, then plunged by 35.33% to -$19.6 million in 2023, then decreased by 0.48% to -$19.7 million in 2024, then increased by 19.59% to -$15.8 million in 2025, then decreased by 16.3% to -$18.4 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$18.4 million, -$15.8 million, and -$19.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 PepGen 217.99 Mn 217.99 Mn - -15.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.84 Mn
Mar 31, 2026 -18.43 Mn
Dec 31, 2025 -15.84 Mn
Sep 30, 2025 -19.36 Mn
Jun 30, 2025 -23.64 Mn
Mar 31, 2025 -23.06 Mn
Dec 31, 2024 -19.70 Mn
Sep 30, 2024 -24.20 Mn
Jun 30, 2024 -16.38 Mn
Mar 31, 2024 -22.59 Mn
Dec 31, 2023 -19.61 Mn
Sep 30, 2023 -16.91 Mn
Jun 30, 2023 -18.48 Mn
Mar 31, 2023 -16.60 Mn
Dec 31, 2022 -14.49 Mn
Sep 30, 2022 -21.40 Mn
Jun 30, 2022 -13.25 Mn
Mar 31, 2022 -13.89 Mn
Dec 31, 2021 -6.14 Mn
Sep 30, 2021 -7.67 Mn